| ²é¿´: 716 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[½»Á÷]
Informative diagnostics for personalized medicine
|
|||
|
Sample TextSample TextSample Text Upstream of an in vitro diagnostic platform, there are outstanding opportunities for chemical biologists to both identify and create affinity recognition strategies for disease biomarkers, which may be discovered at the genomic, transcriptomic, proteomic or metabolomic levels. In the clinic, informative biomarkers may be used in many ways13, including as preclinical diagnostic biomarkers for presymptomatic detection, prognostic biomarkers, which forecast disease progression, and theragnostic biomarkers, which suggest the most appropriate treatment strategy, such as Her2 in the case of trastuzumab. |
» ²ÂÄãϲ»¶
һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸0807 ÊýÒ»Ó¢Ò» 313 ÓÐûÓжþÂÖµ÷¼Á
ÒѾÓÐ12È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ5È˻ظ´
289 ·Ö105500ҩѧר˶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
¿¼Ñе÷¼Á-²ÄÁÏÀà-284
ÒѾÓÐ21È˻ظ´
314Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
0703µ÷¼Á
ÒѾÓÐ19È˻ظ´
Ò»Ö¾Ô¸±±¾©2£¬²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
086004 Çóµ÷¼Á 309
ÒѾÓÐ3È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
³¤½´óѧ»¯¹¤Ñ§Ôº2026Äê˶ʿÑо¿Éúµ÷¼Á¹«¸æ£¨Àíѧ¡¢¹¤Ñ§¾ù¿É£©
+1/90
´óÍåÇø´óѧÀîºì¸ýÓëÖйú¿ÆÑ§¼¼Êõ´óѧÍõÁø½ÌÊÚÁªºÏÕÐÊÕ²©Ê¿ºó
+1/87
½Î÷¿Æ¼¼Ê¦·¶´óѧ ²ÄÁÏÓëÄÜÔ´ÕÐÊÕµ÷¼ÁÑо¿Éú
+1/85
Î÷°²µç×ӿƼ¼´óѧͨÐŹ¤³ÌѧԺÕÐÊÕ ¡°·ÇÈ«ÈÕÖÆ µ÷¼ÁÉú¡°
+2/82
2026ÄêÎ人¹¤³Ì´óѧǧÈ˼ƻ®ÍŶÓÕÐÊÕ˶ʿÑо¿Éúµ÷¼Á
+2/48
¹ã¶«ÎåÒØ´óѧÏÄÍú¿ÎÌâ×é˶ʿµ÷¼Á¹«¸æ
+1/41
¹ã¶«Ê¯ÓÍ»¯¹¤Ñ§ÔºÁõʫӽ½ÌÊÚÍŶӻ¯Ñ§»¯¹¤¡¢²ÄÁÏ¿ÆÑ§µÈ·½ÏòÉÐÓе÷¼ÁÃû¶î
+1/41
»ªÇÈ´óѧ·¢¹â²ÄÁÏÓëÐÅÏ¢ÏÔʾÑо¿ÔºÓÐר˶ºÍѧ˶µ÷¼ÁÕÐÉúÃû¶î
+1/39
ºÓÄÏÖв¿Ä³±¾¿Æ¸ßУ ×ÊÔ´Óë»·¾³£¨×¨Ë¶£©Ñо¿Éú ÕÐÉúÐÅÏ¢
+1/37
±±¾©Àí¹¤´óѧ£¨Ö麣£©ÕÐÊÕ2026¼¶¿¼ºËÖÆ²©Ê¿
+1/15
¹ã¶«¹¤Òµ´óѧÉú̬»·¾³Ó뺣ÑóѧԺÕÅÐù½ÌÊÚ¿ÎÌâ×éÕÐÊÕ·ÖÀëĤÁìÓò2026ÄêÈëѧ²©Ê¿Éú1ÈË
+1/9
ºÓ±±´óѧÕÐÊÕÉúÎïÓëҽҩרҵµ÷¼Á¿¼Éú
+1/8
²³º£´óѧ´¢ÄܲÄÁÏ¿ÎÌâ×éÕÐÊÕµ÷¼ÁÑо¿Éú
+1/7
ÆëÆë¹þ¶û´óѧÀîÀò¿ÎÌâ×é³ÏÕÐ2026¼¶¿¼Ñе÷¼ÁÉú£¨Ñ§Ë¶ºÍר˶£©
+1/5
¼ÃÄÏ´óѧ2026Äê˶ʿÑо¿ÉúÕÐÉúÔ¤µ÷¼Á¹«¸æ
+1/4
»ª±±Àí¹¤´óѧ¿óÎï¼Ó¹¤¹¤³Ì·½Ïò½ÓÊÕµ÷¼ÁÑо¿Éú
+1/4
´óÁ¬¹¤Òµ´óѧ¡°ÇṤ¼¼ÊõÓ빤³Ì¡±¡° ÖÆ½¬ÔìÖ½ÓëÉúÎïÖʾ«Á¶¡±ÁìÓòʯº£Ç¿½ÌÊÚ¿ÎÌâ×éÕÐÊÕ
+1/4
¡¾ÕÐÊÕµ÷¼Á¡¿07/08/09ѧÉú¿´¹ýÀ´ »·¾³ ũҵ Éú̬ѧ ÉúÎï »¯Ñ§ ¼ÆËã»ú ²ÄÁÏ ÊÐÕþ
+1/3
ºÓ±±´óѧ·ÖÎö»¯Ñ§ÕÐÊÕ¶àÃûµ÷¼Á¿¼Éú
+1/3
ÕмÆËã»úµ÷¼Á
+1/2
petrocatal
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 134
- Ó¦Öú: 23 (СѧÉú)
- ¹ó±ö: 0.01
- ½ð±Ò: 3436.6
- Ìû×Ó: 959
- ÔÚÏß: 299.5Сʱ
- ³æºÅ: 557856
ÓÚÌï9858(½ð±Ò+5, ·ÒëEPI+1):лл£¡»¹ÓÐÄØ£¬ÄÜÔÙ°ïÎÒ·ÒëÒ»ÏÂÆäËûµÄÂð 2010-12-05 20:02:50
|
¿ÉΪ¸öÐÔ»¯Ò½Ñ§ÌṩÏà¹ØÐÅÏ¢µÄÕï¶Ï ÔÚÉúÎïÌåÕï¶Ïƽ̨µÄÉÏÓΣ¬ÔÚȾɫÌå×é¡¢·Â¼±¾ÒÔ¼°Ð³´úлˮƽÉÏ£¬ÉúÎﻯѧ¼ÒÓкܺõĻú»áÀ´Ö¤ÊµÓëÓÃÓÚ¼²²¡µÄÉúÎï±ê¼ÇµÄÀàͬÐÔʶ±ð²ßÂÔ¡£ÔÚÖÎÁƹý³ÌÖУ¬ÉúÎï±ê¼ÇÎï¿ÉÌṩÏà¹ØÐÅÏ¢²¢ÓкܶàÀûÓ÷½Ê½£¬°üÀ¨×÷ΪǰÆÚÖÎÁÆ¡¢Õï¶ÏÐÔµÄÉúÎï±ê¼ÇÎï¿ÉÓÃÓÚǰÆÚÖ¢×´µÄ¼ì²â£¬Ô¤Õ×ÐÔµÄÉúÎï±ê¼Ç¿ÉÒÔÔ¤²â¼²²¡µÄ·¢Õ¹£¬theragnostic ÉúÎï±ê¼Ç¿É¶ÔÖÎÁÆÌṩ×îºÏÊʲßÐÔÂÔ½¨Ò飬ÈçHer2ÓÃÓÚÇúÍ×Öéµ¥¿¹ÖС£ |
2Â¥2010-11-28 21:08:14













»Ø¸´´ËÂ¥